NEW YORK (GenomeWeb) – Invitae has launched its initial public offering at $16 per share.
The San Francisco-based molecular diagnostics firm offered 6,350,000 shares of its common stock, bringing in gross proceeds of $101.6 million. It also has granted the underwriters a 30-day option to purchase up to an additional 952,500 shares.
The offering price is above a range of $13 to $15 per share put forth in a preliminary prospectus filed two weeks ago. It also increased the number of shares offered from a previous expectation of 5,350,000.